Eton Pharmaceuticals (ETON) Net Cash Flow (2018 - 2025)

Eton Pharmaceuticals (ETON) has 8 years of Net Cash Flow data on file, last reported at -$11.2 million in Q4 2025.

• For the quarter ending Q4 2025, Net Cash Flow fell 109.93% year-over-year to -$11.2 million; the trailing twelve-month figure through Dec 2025 stood at $11.0 million (up 270.58% YoY), and the FY2025 full-year result was $11.0 million, up 270.58% from the prior year.
• Net Cash Flow slipped to -$11.2 million in Q4 2025, from $11.7 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $11.7 million in Q3 2025 to a low of -$11.2 million in Q4 2025.
• A 5-year average of $197500.0 and a median of $663500.0 in 2022 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow soared 22812.5% in 2022 and sank 680.79% in 2024, its largest moves.
• Tracing ETON's Net Cash Flow over 5 years: stood at -$8.3 million in 2021, then surged by 135.25% to $2.9 million in 2022, then slumped by 123.3% to -$682000.0 in 2023, then slumped by 680.79% to -$5.3 million in 2024, then sank by 109.93% to -$11.2 million in 2025.
• Business Quant data shows ETON's Net Cash Flow at -$11.2 million in Q4 2025, $11.7 million in Q3 2025, and $8.0 million in Q2 2025.